On Monday, Astrazeneca plc ADR (NASDAQ: AZN) opened higher 0.18% from the last session, before settling in for the closing price of $72.88. Price fluctuations for AZN have ranged from $61.24 to $87.68 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 17.27% over the last five years. Company’s average yearly earnings per share was noted 10.20% at the time writing. With a float of $3.10 billion, this company’s outstanding shares have now reached $3.10 billion.
The firm has a total of 94300 workers. Let’s measure their productivity. In terms of profitability, gross margin is 81.39%, operating margin of 19.21%, and the pretax margin is 16.9%.
Astrazeneca plc ADR (AZN) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Astrazeneca plc ADR is 0.01%, while institutional ownership is 16.55%.
Astrazeneca plc ADR (AZN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 10.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.28% during the next five years compared to 34.63% growth over the previous five years of trading.
Astrazeneca plc ADR (NASDAQ: AZN) Trading Performance Indicators
Check out the current performance indicators for Astrazeneca plc ADR (AZN). In the past quarter, the stock posted a quick ratio of 0.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.12. Likewise, its price to free cash flow for the trailing twelve months is 19.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.49, a number that is poised to hit 1.10 in the next quarter and is forecasted to reach 5.09 in one year’s time.
Technical Analysis of Astrazeneca plc ADR (AZN)
Analysing the last 5-days average volume posted by the [Astrazeneca plc ADR, AZN], we can find that recorded value of 3.62 million was lower than the volume posted last year of 5.62 million. As of the previous 9 days, the stock’s Stochastic %D was 79.88%. Additionally, its Average True Range was 1.34.
During the past 100 days, Astrazeneca plc ADR’s (AZN) raw stochastic average was set at 68.77%, which indicates a significant decrease from 86.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.76% in the past 14 days, which was lower than the 26.21% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $69.78, while its 200-day Moving Average is $72.26.
